Mitochondrial dysfunction impairs osteogenesis, increases osteoclast activity, and accelerates age related bone loss

Area of Science:

• Gerontology
• Bone Biology
• Mitochondrial Biology

Background:

• Bone mineral density decline is common in aging but its pathogenesis is unclear.
• Somatic mitochondrial DNA (mtDNA) mutations accumulate with age and are implicated in aging.
• Mitochondrial dysfunction is a universal feature of human aging.

Purpose of the Study:

• To investigate the impact of mitochondrial DNA mutations on bone microarchitecture and turnover.
• To compare bone aging in wild-type mice versus mitochondrial DNA mutator mice (PolgA^mut/mut).

Main Methods:

• Comparison of bone aging in wild-type and PolgA^mut/mut mice.
• In vivo analysis of bone microarchitecture and turnover.
• In vitro assays of osteoblast and osteoclast function.
• Assessment of mitochondrial respiratory chain function in bone cells.
• Evaluation of exercise intervention effects on bone health.

Main Results:

• Accelerated age-related bone loss in PolgA^mut/mut mice compared to wild-type.
• Reduced bone formation rates, osteoblast populations, and mitochondrial respiratory chain function in PolgA^mut/mut mice.
• Impaired mineralized matrix formation and increased osteoclast resorption in PolgA^mut/mut cells.
• Exercise intervention showed no significant effect on bone mass or in vitro matrix formation.

Conclusions:

• Mitochondrial dysfunction, driven by mtDNA mutations, significantly impairs osteogenesis.
• Mitochondrial dysfunction is directly associated with accelerated bone loss during aging.
• Targeting mitochondrial dysfunction may be a potential strategy for age-related bone loss.